Search
for
Sort by
Research 211–240 of 293
- Prevention and management of dermatological toxicities related to anticancer agents: ESMO Clinical Practice Guidelines☆
- Photobiomodulation therapy in management of cancer therapy-induced side effects: WALT position paper 2022
- mTORC1 activity negatively regulates human hair follicle growth and pigmentation
- Telomere Dynamics and Telomerase in the Biology of Hair Follicles and their Stem Cells as a Model for Aging Research
- Eyebrow and Eyelash Alopecia: A Clinical Review
- Treatment Strategies for Cutaneous and Oral Mucosal Side Effects of Oncological Treatment in Breast Cancer: A Comprehensive Review
- Impact of Combined Baricitinib and FTI Treatment on Adipogenesis in Hutchinson–Gilford Progeria Syndrome and Other Lipodystrophic Laminopathies
- Cancer-Related Alopecia: From Etiologies to Global Management
- Optimizing Scalp Cooling: (Ultra)Structural Follicular Characteristic and Restorative Advances
- Determination of the Factors Affecting the Frequency and of Chemotherapy- Induced Alopecia and Methods of Coping with Alopecia
- Provenge is Talk of GU Malignancies Congress
- Cutaneous Neuroimmune Interactions in Peripheral Neuropathic Pain States
- Oral minoxidil for late alopecia in cancer survivors
- Management of Dermatologic Toxicities
- Molecular Targeted Agents and Biologic Therapies for Non-small Cell Lung Cancer
- Management of Skin Toxicities in Cancer Treatment: An Australian/New Zealand Perspective
- Hair Follicles as a Critical Model for Monitoring the Circadian Clock
- Clinical Pathobiology of Radiotherapy-Induced Alopecia: A Guide toward More Effective Prevention and Hair Follicle Repair
- Causes and therapeutic limitations of clinical alopecia and the advent of human pluripotent stem cell follicular transplantation
- Safety First: A Comprehensive Review of Nutritional Supplements for Hair Loss in Breast Cancer Patients
- The potential use of phenolic compounds in the treatment of hair loss: a literature review
- The Impact of Chemotherapy on the Nutritional Status of Breast Cancer Patients
- Gastric cancer; actualities and perspectives of early diagnosis and targeted therapy
- Alopecia
- Permanent alopecia in patients with breast cancer after taxane chemotherapy and adjuvant hormonal therapy: Clinicopathologic findings in a cohort of 10 patients
- Madarosis: a qualitative study to assess perceptions and experience of Australian patients with early breast cancer treated with taxane-based chemotherapy
- 803 Taxane chemotherapy induces epigenetic changes and premature senescence in human scalp hair follicles
- Safety, tolerability, and PK of topical calcitriol formulation for treatment of chemotherapy-induced alopecia (CIA) in patients receiving taxane-based regimen: Final results.
- Assessment of long-term alopecia after adjuvant taxane therapy for early breast cancer: a cross-sectional survey
- Safety and efficacy of low-dose metronomic cyclophosphamide plus vinorelbine in patients with metastatic breast cancer previously treated with anthracyclines and taxanes.